N. Ishioka et al., STIMULATED RAPID EXPRESSION IN-VITRO FOR EARLY DETECTION OF IN-VIVO T-CELL RECEPTOR MUTATIONS INDUCED BY RADIATION EXPOSURE, Mutation research. Genetic toxicology and environmental mutagenesis, 390(3), 1997, pp. 269-282
The T-cell receptor (TCR) mutation assay for in vivo somatic mutations
is a sensitive indicator of exposure to ionizing radiation. However,
this assay cannot be immediately applied after radiation exposure beca
use expression of a mutant phenotype may require as long as several mo
nths. in the present study, we eliminate this time lag by stimulating
lymphocytes with a mitogen that can accelerate the turnover of TCR pro
tein expression in T-cells, When lymphocytes obtained from healthy don
ors were irradiated with various doses of X-rays and cultured with hum
an interleukin-2 after phytohemagglutinin (PHA) pulse stimulation, the
mutant frequency (MF) of CD4(+) T-cells increased dose dependently du
ring the first 7 days, then decreased rapidly due to the growth disadv
antage of mutant cells. This suggests that PHA stimulation can shorten
the expression time of a mutant phenotype to within a week after radi
ation exposure. The relationship between radiation dose and TCR IMF on
the seventh day was best fitted by a linear-quadratic dose-response m
odel. We applied this improved TCR mutation assay to gynecological can
cer patients who received 5 days of localized radiotherapy, totaling a
bout 10 Gy. The in vivo TCR MF in the patients did not change within a
week after radiotherapy, whereas the in vitro TCR MF of PHA-stimulate
d lymphocytes from the same patients significantly increased 7 days af
ter initiating culture. The estimated mean radiation dose to the perip
heral blood lymphocytes of the cancer patients was about 0.9 Gy, based
on the in vitro linear-quadratic dose-response curve. This estimated
dose was close to that described in a previous report an unstable-type
chromosome aberrations from cervical cancer patients after receiving
the same course of radiotherapy, On the basis of these findings, we pr
opose that the improved TCR mutation assay is a useful biological dosi
meter for recent radiation exposure.